These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague. Tao P; Mahalingam M; Zhu J; Moayeri M; Sha J; Lawrence WS; Leppla SH; Chopra AK; Rao VB mBio; 2018 Oct; 9(5):. PubMed ID: 30327445 [No Abstract] [Full Text] [Related]
6. Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection. Barnes KB; Richards MI; Laws TR; Núñez A; Thwaite JE; Bentley C; Harding SV Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753342 [TBL] [Abstract][Full Text] [Related]
7. Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Klimpel GR; Eaves-Pyles T; Moen ST; Taormina J; Peterson JW; Chopra AK; Niesel DW; Carness P; Haithcoat JL; Kirtley M; Nasr AB Vaccine; 2008 Dec; 26(52):6874-82. PubMed ID: 18930100 [TBL] [Abstract][Full Text] [Related]
8. Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents - review. Pohanka M; Skládal P Folia Microbiol (Praha); 2009; 54(4):263-72. PubMed ID: 19826916 [TBL] [Abstract][Full Text] [Related]
9. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague. Campbell JL; Fay MP; Lanning LL; Hewitt JA Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of two multiplex real-time PCR screening capabilities for the detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples generated from murine infection models. Weller SA; Cox V; Essex-Lopresti A; Hartley MG; Parsons TM; Rachwal PA; Stapleton HL; Lukaszewski RA J Med Microbiol; 2012 Nov; 61(Pt 11):1546-1555. PubMed ID: 22899777 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Brouillard JE; Terriff CM; Tofan A; Garrison MW Pharmacotherapy; 2006 Jan; 26(1):3-14. PubMed ID: 16506347 [TBL] [Abstract][Full Text] [Related]
15. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160 [TBL] [Abstract][Full Text] [Related]
16. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis. Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284 [TBL] [Abstract][Full Text] [Related]
17. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques. Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261 [TBL] [Abstract][Full Text] [Related]
18. Multiplex Detection of Three Select Agents Directly from Blood by Use of the GeneXpert System. Banada PP; Deshpande S; Banik S; Shah D; Koshy R; Patel B; Kwiatkowski R; Persing D; Alland D J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842226 [No Abstract] [Full Text] [Related]
19. Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis. O'Malley KJ; Bowling JD; Barry EM; Hazlett KRO; Reed DS Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085702 [TBL] [Abstract][Full Text] [Related]
20. A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Tao P; Mahalingam M; Zhu J; Moayeri M; Kirtley ML; Fitts EC; Andersson JA; Lawrence WS; Leppla SH; Chopra AK; Rao VB Front Immunol; 2017; 8():687. PubMed ID: 28694806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]